Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
|---|---|---|---|---|---|
| C0205699 | Carcinomatosis | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
| C0030486 | Paraplegia | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
| C0001815 | Primary Myelofibrosis | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
| C1861821 | CATARACT, MARNER TYPE | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
| C0862312 | Epithelioid mesothelioma, malignant | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
| C1412036 | Anal squamous cell carcinoma | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
| C0684354 | Benign neoplasm of sweat gland | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
| C1833921 | Familial medullary thyroid carcinoma | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
| C0338831 | Manic | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
| C0014850 | Esophageal Atresia | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
| C0376358 | Malignant neoplasm of prostate | CLGN | 1047 | calmegin | O14967 |
| C0036631 | Seminoma | CLGN | 1047 | calmegin | O14967 |
| C0600139 | Prostate carcinoma | CLGN | 1047 | calmegin | O14967 |
| C0678222 | Breast Carcinoma | CLGN | 1047 | calmegin | O14967 |
| C0006142 | Malignant neoplasm of breast | CLGN | 1047 | calmegin | O14967 |
| C0282577 | Congenital Disorders of Glycosylation | COG5 | 10466 | component of oligomeric golgi complex 5 | Q9UP83 |
| C3714756 | Intellectual Disability | COG5 | 10466 | component of oligomeric golgi complex 5 | Q9UP83 |
| C0520947 | Clumsiness - motor delay | COG5 | 10466 | component of oligomeric golgi complex 5 | Q9UP83 |
| C0010417 | Cryptorchidism | COG5 | 10466 | component of oligomeric golgi complex 5 | Q9UP83 |
| C1956346 | Coronary Artery Disease | COG5 | 10466 | component of oligomeric golgi complex 5 | Q9UP83 |
| C3150876 | COG5 congenital disorder of glycosylation | COG5 | 10466 | component of oligomeric golgi complex 5 | Q9UP83 |
| C0004238 | Atrial Fibrillation | COG5 | 10466 | component of oligomeric golgi complex 5 | Q9UP83 |
| C0235480 | Paroxysmal atrial fibrillation | COG5 | 10466 | component of oligomeric golgi complex 5 | Q9UP83 |
| C0016719 | Friedreich Ataxia | COG5 | 10466 | component of oligomeric golgi complex 5 | Q9UP83 |
| C0036572 | Seizures | COG5 | 10466 | component of oligomeric golgi complex 5 | Q9UP83 |
